CTI(SZ:300012) Zhong Guo Jing Ji Wang·2025-06-27 03:49Core Viewpoint - The share transfer plan of Huace Testing involves the transfer of up to 17.26 million shares to the actual controller's action group, which will not change the total shareholding of the actual controller and its concerted actors, maintaining a 22.06% stake in the company [1][2]. Group 1: Share Transfer Details - The transfer will occur through block trading and will not exceed 1.031% of the company's total share capital after excluding repurchased shares [1]. - The transfer period is set from July 21, 2025, to October 20, 2025, with trading prices determined by the secondary market [1]. - After the transfer, the actual controller's total shareholding will remain unchanged at 371,183,884 shares [1][2]. Group 2: Financial Performance - Huace Testing's revenue for 2022, 2023, and 2024 is reported as 5.13 billion, 5.60 billion, and 6.08 billion yuan respectively, showing an increase of 8.55% from 2023 to 2024 [2][3]. - The net profit attributable to shareholders for the same years is 9.03 billion, 9.10 billion, and 9.21 billion yuan, indicating a slight increase of 1.19% from 2023 to 2024 [2][3]. - The cash flow from operating activities for 2022, 2023, and 2024 is reported as 11.00 billion, 11.22 billion, and 10.63 billion yuan, with a decrease in 2024 [2][3]. Group 3: Recent Quarterly Performance - In Q1 2025, the company reported a revenue of 1.29 billion yuan, a year-on-year increase of 7.96% [4][5]. - The net profit attributable to shareholders for Q1 2025 is 136.19 million yuan, reflecting a 2.75% increase compared to the same period last year [4][5]. - The net cash flow from operating activities for Q1 2025 is reported at -89.94 million yuan, showing a significant improvement of 47.10% year-on-year [4][5].